nodes	percent_of_prediction	percent_of_DWPC	metapath
Zaleplon—Goitre—Octreotide—thymus cancer	0.037	0.038	CcSEcCtD
Zaleplon—VIIth nerve paralysis—Octreotide—thymus cancer	0.0322	0.033	CcSEcCtD
Zaleplon—Ulcerative stomatitis—Octreotide—thymus cancer	0.0286	0.0294	CcSEcCtD
Zaleplon—Sinus bradycardia—Octreotide—thymus cancer	0.0269	0.0276	CcSEcCtD
Zaleplon—Renal pain—Octreotide—thymus cancer	0.0251	0.0258	CcSEcCtD
Zaleplon—Cholelithiasis—Octreotide—thymus cancer	0.0213	0.0218	CcSEcCtD
Zaleplon—Hypothyroidism—Octreotide—thymus cancer	0.0206	0.0211	CcSEcCtD
Zaleplon—Peptic ulcer—Octreotide—thymus cancer	0.0198	0.0203	CcSEcCtD
Zaleplon—Intestinal obstruction—Octreotide—thymus cancer	0.0194	0.0199	CcSEcCtD
Zaleplon—Neuralgia—Octreotide—thymus cancer	0.019	0.0195	CcSEcCtD
Zaleplon—Metrorrhagia—Octreotide—thymus cancer	0.0185	0.019	CcSEcCtD
Zaleplon—Nephrolithiasis—Octreotide—thymus cancer	0.0164	0.0169	CcSEcCtD
Zaleplon—Breast pain—Octreotide—thymus cancer	0.0151	0.0155	CcSEcCtD
Zaleplon—Rectal haemorrhage—Octreotide—thymus cancer	0.0146	0.015	CcSEcCtD
Zaleplon—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0145	0.0149	CcSEcCtD
Zaleplon—Arthropathy—Octreotide—thymus cancer	0.0145	0.0149	CcSEcCtD
Zaleplon—Vaginal inflammation—Octreotide—thymus cancer	0.0132	0.0136	CcSEcCtD
Zaleplon—Eructation—Octreotide—thymus cancer	0.013	0.0133	CcSEcCtD
Zaleplon—Cystitis noninfective—Octreotide—thymus cancer	0.0129	0.0132	CcSEcCtD
Zaleplon—Cystitis—Octreotide—thymus cancer	0.0128	0.0131	CcSEcCtD
Zaleplon—Vaginal infection—Octreotide—thymus cancer	0.0125	0.0128	CcSEcCtD
Zaleplon—Neuropathy—Octreotide—thymus cancer	0.0124	0.0127	CcSEcCtD
Zaleplon—Bladder pain—Octreotide—thymus cancer	0.0119	0.0123	CcSEcCtD
Zaleplon—Mouth ulceration—Octreotide—thymus cancer	0.0119	0.0123	CcSEcCtD
Zaleplon—Hyperkinesia—Octreotide—thymus cancer	0.0115	0.0118	CcSEcCtD
Zaleplon—Thrombophlebitis—Octreotide—thymus cancer	0.0111	0.0114	CcSEcCtD
Zaleplon—Diabetes mellitus—Octreotide—thymus cancer	0.011	0.0113	CcSEcCtD
Zaleplon—Gastroenteritis—Octreotide—thymus cancer	0.0108	0.0111	CcSEcCtD
Zaleplon—Deafness—Octreotide—thymus cancer	0.0107	0.011	CcSEcCtD
Zaleplon—Amnesia—Octreotide—thymus cancer	0.0102	0.0105	CcSEcCtD
Zaleplon—Anaphylactoid reaction—Octreotide—thymus cancer	0.00991	0.0102	CcSEcCtD
Zaleplon—Arthritis—Octreotide—thymus cancer	0.00987	0.0101	CcSEcCtD
Zaleplon—Hypoglycaemia—Octreotide—thymus cancer	0.00983	0.0101	CcSEcCtD
Zaleplon—Osteoarthritis—Octreotide—thymus cancer	0.00959	0.00984	CcSEcCtD
Zaleplon—Psychotic disorder—Octreotide—thymus cancer	0.00937	0.00961	CcSEcCtD
Zaleplon—Irritability—Octreotide—thymus cancer	0.00916	0.00939	CcSEcCtD
Zaleplon—Dry skin—Octreotide—thymus cancer	0.00879	0.00902	CcSEcCtD
Zaleplon—Gastritis—Octreotide—thymus cancer	0.00849	0.00871	CcSEcCtD
Zaleplon—Muscular weakness—Octreotide—thymus cancer	0.00846	0.00868	CcSEcCtD
Zaleplon—Asthma—Octreotide—thymus cancer	0.00829	0.0085	CcSEcCtD
Zaleplon—Bronchitis—Octreotide—thymus cancer	0.00797	0.00818	CcSEcCtD
Zaleplon—Dysuria—Octreotide—thymus cancer	0.00775	0.00795	CcSEcCtD
Zaleplon—Pollakiuria—Octreotide—thymus cancer	0.00766	0.00786	CcSEcCtD
Zaleplon—Weight increased—Octreotide—thymus cancer	0.00755	0.00774	CcSEcCtD
Zaleplon—Weight decreased—Octreotide—thymus cancer	0.0075	0.00769	CcSEcCtD
Zaleplon—Hyperglycaemia—Octreotide—thymus cancer	0.00748	0.00767	CcSEcCtD
Zaleplon—Pneumonia—Octreotide—thymus cancer	0.00744	0.00763	CcSEcCtD
Zaleplon—Depression—Octreotide—thymus cancer	0.00737	0.00756	CcSEcCtD
Zaleplon—Neuropathy peripheral—Octreotide—thymus cancer	0.00725	0.00743	CcSEcCtD
Zaleplon—Conjunctivitis—Octreotide—thymus cancer	0.00719	0.00737	CcSEcCtD
Zaleplon—Haematuria—Octreotide—thymus cancer	0.00705	0.00723	CcSEcCtD
Zaleplon—Hepatobiliary disease—Octreotide—thymus cancer	0.00699	0.00717	CcSEcCtD
Zaleplon—Epistaxis—Octreotide—thymus cancer	0.00697	0.00715	CcSEcCtD
Zaleplon—Hypoaesthesia—Octreotide—thymus cancer	0.0066	0.00677	CcSEcCtD
Zaleplon—Oedema peripheral—Octreotide—thymus cancer	0.00654	0.00671	CcSEcCtD
Zaleplon—Visual impairment—Octreotide—thymus cancer	0.0064	0.00656	CcSEcCtD
Zaleplon—Tinnitus—Octreotide—thymus cancer	0.00619	0.00635	CcSEcCtD
Zaleplon—Immune system disorder—Octreotide—thymus cancer	0.00599	0.00615	CcSEcCtD
Zaleplon—Alopecia—Octreotide—thymus cancer	0.00586	0.00602	CcSEcCtD
Zaleplon—Mental disorder—Octreotide—thymus cancer	0.00581	0.00596	CcSEcCtD
Zaleplon—Malnutrition—Octreotide—thymus cancer	0.00578	0.00593	CcSEcCtD
Zaleplon—Flatulence—Octreotide—thymus cancer	0.00569	0.00584	CcSEcCtD
Zaleplon—Tension—Octreotide—thymus cancer	0.00567	0.00581	CcSEcCtD
Zaleplon—Nervousness—Octreotide—thymus cancer	0.00561	0.00576	CcSEcCtD
Zaleplon—Back pain—Octreotide—thymus cancer	0.00559	0.00573	CcSEcCtD
Zaleplon—Tremor—Octreotide—thymus cancer	0.00541	0.00555	CcSEcCtD
Zaleplon—Ill-defined disorder—Octreotide—thymus cancer	0.00536	0.0055	CcSEcCtD
Zaleplon—Anaemia—Octreotide—thymus cancer	0.00534	0.00548	CcSEcCtD
Zaleplon—Agitation—Octreotide—thymus cancer	0.00531	0.00545	CcSEcCtD
Zaleplon—Malaise—Octreotide—thymus cancer	0.00521	0.00534	CcSEcCtD
Zaleplon—Vertigo—Octreotide—thymus cancer	0.00519	0.00532	CcSEcCtD
Zaleplon—Syncope—Octreotide—thymus cancer	0.00518	0.00531	CcSEcCtD
Zaleplon—Palpitations—Octreotide—thymus cancer	0.00511	0.00524	CcSEcCtD
Zaleplon—Loss of consciousness—Octreotide—thymus cancer	0.00508	0.00521	CcSEcCtD
Zaleplon—Hypertension—Octreotide—thymus cancer	0.00499	0.00512	CcSEcCtD
Zaleplon—Arthralgia—Octreotide—thymus cancer	0.00492	0.00504	CcSEcCtD
Zaleplon—Chest pain—Octreotide—thymus cancer	0.00492	0.00504	CcSEcCtD
Zaleplon—Myalgia—Octreotide—thymus cancer	0.00492	0.00504	CcSEcCtD
Zaleplon—Anxiety—Octreotide—thymus cancer	0.0049	0.00503	CcSEcCtD
Zaleplon—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00488	0.00501	CcSEcCtD
Zaleplon—Discomfort—Octreotide—thymus cancer	0.00486	0.00498	CcSEcCtD
Zaleplon—Dry mouth—Octreotide—thymus cancer	0.00481	0.00493	CcSEcCtD
Zaleplon—Oedema—Octreotide—thymus cancer	0.00471	0.00484	CcSEcCtD
Zaleplon—Anaphylactic shock—Octreotide—thymus cancer	0.00471	0.00484	CcSEcCtD
Zaleplon—Shock—Octreotide—thymus cancer	0.00464	0.00476	CcSEcCtD
Zaleplon—Nervous system disorder—Octreotide—thymus cancer	0.00462	0.00474	CcSEcCtD
Zaleplon—Tachycardia—Octreotide—thymus cancer	0.0046	0.00472	CcSEcCtD
Zaleplon—Skin disorder—Octreotide—thymus cancer	0.00458	0.0047	CcSEcCtD
Zaleplon—Hyperhidrosis—Octreotide—thymus cancer	0.00456	0.00468	CcSEcCtD
Zaleplon—Anorexia—Octreotide—thymus cancer	0.00449	0.00461	CcSEcCtD
Zaleplon—Musculoskeletal discomfort—Octreotide—thymus cancer	0.0043	0.00441	CcSEcCtD
Zaleplon—Insomnia—Octreotide—thymus cancer	0.00426	0.00437	CcSEcCtD
Zaleplon—Paraesthesia—Octreotide—thymus cancer	0.00423	0.00434	CcSEcCtD
Zaleplon—Dyspnoea—Octreotide—thymus cancer	0.0042	0.00431	CcSEcCtD
Zaleplon—Somnolence—Octreotide—thymus cancer	0.00419	0.0043	CcSEcCtD
Zaleplon—Dyspepsia—Octreotide—thymus cancer	0.00415	0.00426	CcSEcCtD
Zaleplon—Decreased appetite—Octreotide—thymus cancer	0.0041	0.0042	CcSEcCtD
Zaleplon—Gastrointestinal disorder—Octreotide—thymus cancer	0.00407	0.00418	CcSEcCtD
Zaleplon—Pain—Octreotide—thymus cancer	0.00403	0.00414	CcSEcCtD
Zaleplon—Constipation—Octreotide—thymus cancer	0.00403	0.00414	CcSEcCtD
Zaleplon—Feeling abnormal—Octreotide—thymus cancer	0.00389	0.00399	CcSEcCtD
Zaleplon—Gastrointestinal pain—Octreotide—thymus cancer	0.00386	0.00395	CcSEcCtD
Zaleplon—Urticaria—Octreotide—thymus cancer	0.00375	0.00384	CcSEcCtD
Zaleplon—Body temperature increased—Octreotide—thymus cancer	0.00373	0.00382	CcSEcCtD
Zaleplon—Abdominal pain—Octreotide—thymus cancer	0.00373	0.00382	CcSEcCtD
Zaleplon—Asthenia—Octreotide—thymus cancer	0.00338	0.00347	CcSEcCtD
Zaleplon—Pruritus—Octreotide—thymus cancer	0.00334	0.00342	CcSEcCtD
Zaleplon—Dizziness—Octreotide—thymus cancer	0.00312	0.0032	CcSEcCtD
Zaleplon—Rash—Octreotide—thymus cancer	0.00297	0.00305	CcSEcCtD
Zaleplon—Dermatitis—Octreotide—thymus cancer	0.00297	0.00305	CcSEcCtD
Zaleplon—Headache—Octreotide—thymus cancer	0.00295	0.00303	CcSEcCtD
Zaleplon—Nausea—Octreotide—thymus cancer	0.0028	0.00287	CcSEcCtD
Zaleplon—TSPO—neck—thymus cancer	0.00203	0.081	CbGeAlD
Zaleplon—TSPO—hematopoietic system—thymus cancer	0.00151	0.0603	CbGeAlD
Zaleplon—TSPO—epithelium—thymus cancer	0.00138	0.0551	CbGeAlD
Zaleplon—AOX1—cardiac atrium—thymus cancer	0.00134	0.0536	CbGeAlD
Zaleplon—GABRG2—pituitary gland—thymus cancer	0.00132	0.0529	CbGeAlD
Zaleplon—AOX1—pituitary gland—thymus cancer	0.00131	0.0524	CbGeAlD
Zaleplon—TSPO—cardiac atrium—thymus cancer	0.00115	0.0458	CbGeAlD
Zaleplon—AOX1—thyroid gland—thymus cancer	0.00113	0.0451	CbGeAlD
Zaleplon—TSPO—pituitary gland—thymus cancer	0.00112	0.0447	CbGeAlD
Zaleplon—TSPO—lymphoid tissue—thymus cancer	0.00106	0.0424	CbGeAlD
Zaleplon—GABRB2—lung—thymus cancer	0.00104	0.0414	CbGeAlD
Zaleplon—AOX1—lung—thymus cancer	0.00103	0.041	CbGeAlD
Zaleplon—GABRB3—pituitary gland—thymus cancer	0.00102	0.0406	CbGeAlD
Zaleplon—TSPO—bone marrow—thymus cancer	0.000968	0.0386	CbGeAlD
Zaleplon—TSPO—thyroid gland—thymus cancer	0.000966	0.0385	CbGeAlD
Zaleplon—CYP3A5—hematopoietic system—thymus cancer	0.000935	0.0373	CbGeAlD
Zaleplon—TSPO—lung—thymus cancer	0.000877	0.035	CbGeAlD
Zaleplon—GABRB3—thyroid gland—thymus cancer	0.000877	0.035	CbGeAlD
Zaleplon—GABRB3—lung—thymus cancer	0.000796	0.0318	CbGeAlD
Zaleplon—AOX1—lymph node—thymus cancer	0.000702	0.028	CbGeAlD
Zaleplon—CYP3A4—hematopoietic system—thymus cancer	0.000702	0.028	CbGeAlD
Zaleplon—GABRA2—lymph node—thymus cancer	0.000648	0.0259	CbGeAlD
Zaleplon—TSPO—lymph node—thymus cancer	0.0006	0.0239	CbGeAlD
Zaleplon—CYP3A5—lung—thymus cancer	0.000543	0.0217	CbGeAlD
